X0306 4 2016-01-04 0 0001610092 Diplomat Pharmacy, Inc. DPLO 0001619008 Kaddis Atheer A 4100 S. SAGINAW STREET FLINT MI 48507 0 1 0 0 SVP of Sales & Business Dev. Common Stock 2016-01-04 4 M 0 12325 3.07 A 12325 D Common Stock 2016-01-04 4 S 0 9700 33.4266 D 2625 D Common Stock 2016-01-04 4 S 0 2625 33.9632 D 0 D Employee Stock Option to Acquire Common Stock 3.07 2016-01-04 4 M 0 12325 0 D 2019-04-01 Common Stock 12325 382075 D The sale was effected pursuant to a 10b5-1 trading plan initially adopted by the reporting person on August 6, 2015. The plan provides for monthly sales of 12,325 shares of common stock at the market price. Shares that are not sold in a particular month will be available for sale in subsequent months under the plan. A maximum of 86,275 shares remain available for sale under the plan, which is set to expire on August 31, 2016. The price represents the weighted average price of the multiple transactions reported on this line. The shares were sold at prices ranging from $32.86 to $33.83 per share. Upon request by the SEC staff, the issuer or any securityholder of the issuer, the reporting person will provide full information regarding the number of shares sold at each separate price. The price represents the weighted average price of the multiple transactions reported on this line. The shares were sold at prices ranging from $33.86 to $34.07 per share. Upon request by the SEC staff, the issuer or any securityholder of the issuer, the reporting person will provide full information regarding the number of shares sold at each separate price. The options were granted on April 1, 2009. The options began to vest in annual increments of 25% of the option grant on the one-year anniversary of the grant date, to be fully vested after four years. 100% of the options originally granted are currently vested and exercisable. Jeffrey H. Kuras, Attorney-in-fact 2016-01-05